Stanford scientists have developed a strategy that enables simultaneous and combinatorial genetic screening across different types of genetic perturbations (gene knockouts, knock-ins, overexpression, and gene domain modification).
Researchers at Stanford have harnessed nanoprobes to longitudinally track immune system activation at a single-cell level, in response to immunotherapies.